John R. Hadcock

3.6k citations

60 papers · 2.9k indexed · h-index 31

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 2%
Physiology top 5%
Endocrinology, Diabetes and Metabolism top 5%
Epidemiology top 10%

Co-authors: C C Malbon Joann Strnad Manuel Ros Craig C. Malbon J. David Port Mark H. Pausch Laura A. Price David C. Watkins
Topics: Receptor Mechanisms and Signaling (28 papers)Pharmacological Effects and Assays (11 papers)Adipose Tissue and Metabolism (10 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Endocrine and Autonomic Systems
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States United Kingdom Australia

In The Last Decade

John R. Hadcock

60 papers receiving 2.8k citations

Peers

Countries citing papers authored by John R. Hadcock

Since Specialization

Citations

This map shows the geographic impact of John R. Hadcock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Hadcock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Hadcock more than expected).

Fields of papers citing papers by John R. Hadcock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Hadcock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Hadcock. The network helps show where John R. Hadcock may publish in the future.

Co-authorship network of co-authors of John R. Hadcock

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Hadcock. A scholar is included among the top collaborators of John R. Hadcock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Hadcock. John R. Hadcock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beneficial Metabolic Effects of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in a Mouse Diet-Induced Obesity Model 2022 ·Frontiers in Pharmacology ·(unknown),John R. Hadcock,Guang Liu,(unknown),Julien Roux,Courtney Shea,Emmanuel S. Buys,Juli E. Jones	2
2	Pharmacokinetic/Pharmacodynamic Modeling of a Cell-Penetrating Peptide Phosphorodiamidate Morpholino Oligomer in mdx Mice 2021 ·Pharmaceutical Research ·(unknown),(unknown),(unknown),Jianbo Zhang,Jenna Wood,(unknown),(unknown),(unknown),Huadong Sun,Mohammad Shadid,Shawn Harriman,John R. Hadcock	10
3	Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential 2018 ·Nitric Oxide ·Emmanuel S. Buys,(unknown),(unknown),(unknown),Yueh‐tyng Chien,Albert T. Profy,John R. Hadcock,Jaime L. Masferrer,G. Todd Milne	56
4	The Clinical-Stage sGC Stimulator IW-1701 Prevents Increase of Plasma Biomarkers of Intravascular Inflammation and Suppresses Leukocyte-Endothelial Interactions in Tnfα-Treated Mice 2017 ·Blood ·Boris Tchernychev,Susanne Feil,(unknown),William P. Warren,(unknown),Robert Feil,(unknown),John R. Hadcock,Yueh‐tyng Chien,Mark G. Currie,(unknown)	4
5	G protein–coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice 2012 ·Journal of Clinical Investigation ·Olivia Osborn,Da Young Oh,Joanne McNelis,Manuel Sánchez-Alavez,Saswata Talukdar,Min Lü,Pingping Li,(unknown),Hidetaka Morinaga,Jane J. Kim,(unknown),(unknown),Jachelle M. Ofrecio,Miriam Scadeng,Simon Schenk,John R. Hadcock,Tamás Bartfai,Jerrold M. Olefsky	42
6	Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin 2012 ·Metabolism ·Jeffrey S. Dubins,Manuel Sánchez-Alavez,(unknown),Alejandro Sánchez-González,Gianluca Moroncini,Santos Carvajal‐Gonzalez,John R. Hadcock,Tamás Bartfai,Bruno Conti	17
7	Postnatal PPARδ Activation and Myostatin Inhibition Exert Distinct yet Complimentary Effects on the Metabolic Profile of Obese Insulin-Resistant Mice 2010 ·PLoS ONE ·Barbara Bernardo,(unknown),Patricia G. Cosgrove,Max Kühn,Alan Opsahl,(unknown),Thomas B. Freeman,John R. Hadcock,Nathan K. LeBrasseur	57
8	Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist 2010 ·BMC Pharmacology ·John R. Hadcock,Philip A. Carpino,Philip A. Iredale,Robert L. Dow,(unknown),(unknown),Dawn Kelly-Sullivan,(unknown),Xingrong Liu,(unknown),Karen Ward,Rebecca E. O’Connor,Shawn C. Black,David A. Griffith,Dennis O. Scott	12
9	Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles 2009 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Dow,John R. Hadcock,Dennis O. Scott,(unknown),Ernest S. Paight,Philip A. Iredale,Philip A. Carpino,David A. Griffith,Marlys Hammond,Paul DaSilva‐Jardine	11
10	Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Xuebing Cao,Liang Li,John R. Hadcock,Philip A. Iredale,David A. Griffith,Frank S. Menniti,Stewart A. Factor,J. Timothy Greenamyre,Stella M. Papa	82
11	Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer Lafontaine,(unknown),(unknown),John R. Hadcock,Diane M. Hargrove,Michael C. Linhares,Kelly A. Martin,Tristan S. Maurer,Nancy A. Nardone,David A. Tess,Paul DaSilva‐Jardine	14
12	Potent and selective, sulfamide-based human β3-adrenergic receptor agonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Dow,Ernest S. Paight,(unknown),John R. Hadcock,Diane M. Hargrove,Kelly A. Martin,Tristan S. Maurer,Nancy A. Nardone,David A. Tess,Paul DaSilva‐Jardine	13
13	Effects of alpha2-adrenoceptor antagonists on metabolic processes of swine: I. Effects on nonesterified fatty acid and plasma urea nitrogen concentrations in jugularly catheterized pigs. 1998 ·Journal of Animal Science ·R.M. Cleale,(unknown),(unknown),John R. Hadcock,Mark H. Pausch	2
14	Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway. 1996 ·Molecular Pharmacology ·Laura A. Price,Joann Strnad,Mark H. Pausch,John R. Hadcock	47
15	The Rat SSTR2 Somatostatin Receptor Subtype Is Coupled to Inhibition of Cyclic AMP Accumulation 1993 ·Biochemical and Biophysical Research Communications ·Joann Strnad,C. Mark Eppler,(unknown),John R. Hadcock	37
16	Agonist Regulation of Gene Expression of Adrenergic Receptors and G Proteins 1993 ·Journal of Neurochemistry ·John R. Hadcock,(unknown)	108
17	Regulation of receptor expression by agonists: transcriptional and post-transcriptional controls 1991 ·Trends in Neurosciences ·John R. Hadcock,(unknown)	89
18	Photoaffinity Labeling of the Guinea Pig Pulmonary Mast Cell β-adrenergic Receptor 1989 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown),Filomena Graziano,(unknown),John R. Hadcock,C C Malbon,Arnold E. Ruoho	3
19	Receptor density and cAMP accumulation: Analysis in CHO cells exhibiting stable expression of a cDNA that encodes the beta2-adrenergic receptor 1988 ·Biochemical and Biophysical Research Communications ·Shaji T. George,Miguel Berríos,John R. Hadcock,Hsien‐yu Wang,Craig C. Malbon	50
20	Evidence that glucocorticoid response elements in the 5′-noncoding region of the hamster β2-adrenergic receptor gene are obligate for glucocoticoid regulation of receptor mRNA levels 1988 ·Biochemical and Biophysical Research Communications ·Craig C. Malbon,John R. Hadcock	66

About John R. Hadcock

John R. Hadcock is a scholar working on Animal Science and Zoology, Endocrine and Autonomic Systems and Cellular and Molecular Neuroscience, having authored 60 papers that have together received 2.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (28 papers), Pharmacological Effects and Assays (11 papers) and Adipose Tissue and Metabolism (10 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (896 citations), Behavioral Neuroscience (122 citations) and Endocrine and Autonomic Systems (181 citations). John R. Hadcock has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include C C Malbon, Joann Strnad, Manuel Ros, Craig C. Malbon, J. David Port, Mark H. Pausch, Laura A. Price, David C. Watkins, Rodney A. Bednar and Marina S. Gelman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact